NEI Research News

Research team has identified advanced preclinical candidates targeting the bisretinoid synthesis pathway, which could help treat macular degeneration and Stargardt disease.

New research suggests long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of shingles-related eye inflammation, infection, and pain.

Too much stuff in the periphery of our vision can make it difficult to identify what we’re seeing. Yale researchers now know how that clutter affects the brain.

New research from the University of Rochester provides important insights into the cellular mechanisms behind AMD and offers potential avenues for new treatments.

A new study reveals how the eye resolves inflammation in the eye disease autoimmune uveitis.

New research from UChicago shows that the superior colliculus, a brain region that controls eye movements, also plays an important role in higher cognitive functions like categorization and decision making.

New data demonstrate how social determinants of health can fuel disparities in monitoring for diabetic retinopathy for patients of different racial and ethnic groups.

Researchers are searching for a new treatment target for a common complication of diabetes that can cause retinal blood vessels to break down, leak or become blocked.

NEI-funded team demonstrates for the first time that cytokines play an important role in the development and regeneration of the retinal cells that degenerate in glaucoma.

The team identified small molecules that can reduce the production of proteins linked to age-related macular degeneration.